|
US4296206A
(en)
|
1980-04-30 |
1981-10-20 |
United States Of America |
Irreversible anti-glucocorticoids
|
|
ZA8231B
(en)
|
1981-01-09 |
1982-11-24 |
Roussel Uclaf |
New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
|
|
FR2528434B1
(fr)
|
1982-06-11 |
1985-07-19 |
Roussel Uclaf |
Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
|
|
US4978657A
(en)
|
1981-01-09 |
1990-12-18 |
Roussel Uclaf |
Novel 11β-substituted-19-nor-steroids
|
|
FR2522328B1
(fr)
|
1982-03-01 |
1986-02-14 |
Roussel Uclaf |
Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
|
|
FR2639045B2
(fr)
|
1982-03-01 |
1994-07-29 |
Roussel Uclaf |
Nouveaux produits derives de la structure 3-ceto-delta-4,9-19-nor steroides et leur application comme medicaments
|
|
DE3438994A1
(de)
|
1984-10-22 |
1986-04-24 |
Schering AG, Berlin und Bergkamen, 1000 Berlin |
Antigestagene, glukokortikoide und prostaglandine zur geburtseinleitung oder fuer den schwangerschaftsabbruch
|
|
FR2576025B1
(fr)
|
1985-01-14 |
1987-01-23 |
Roussel Uclaf |
Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant
|
|
AU580843B2
(en)
|
1985-02-07 |
1989-02-02 |
Schering Aktiengesellschaft |
11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them
|
|
DE3506785A1
(de)
|
1985-02-22 |
1986-08-28 |
Schering AG, Berlin und Bergkamen, 1000 Berlin |
11ss-n,n-dimethylaminophenyl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
|
|
US5382661A
(en)
|
1985-09-12 |
1995-01-17 |
The Upjohn Company |
Pyrazinylpiperazinyl steroids
|
|
FR2598421B1
(fr)
|
1986-05-06 |
1988-08-19 |
Roussel Uclaf |
Nouveaux produits 19-nor ou 19-nor d-homo steroides substitues en position 11b par un radical phenyle portant un radical alkynyle, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
|
|
DE3761308D1
(de)
|
1986-07-23 |
1990-02-08 |
Akzo Nv |
18-phenylestrane-derivate.
|
|
DE3625315A1
(de)
|
1986-07-25 |
1988-01-28 |
Schering Ag |
11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate
|
|
US4861763A
(en)
|
1986-09-17 |
1989-08-29 |
Research Triangle Institute |
17 α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and their progestational use
|
|
US4774236A
(en)
|
1986-09-17 |
1988-09-27 |
Research Triangle Institute |
17α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and pharmaceutical compositions containing them
|
|
US4921638A
(en)
|
1986-11-05 |
1990-05-01 |
The Upjohn Company |
17β-cyano-9α,17α-dihydroxyandrost-4-en-3-one
|
|
DE3708942A1
(de)
|
1987-03-18 |
1988-09-29 |
Schering Ag |
19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
|
|
DE3723788A1
(de)
|
1987-07-16 |
1989-01-26 |
Schering Ag |
11(beta)-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate
|
|
FR2618783B1
(fr)
|
1987-07-30 |
1991-02-01 |
Roussel Uclaf |
Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant
|
|
BE1004905A4
(fr)
|
1987-12-30 |
1993-02-23 |
Roussel Uclaf |
Nouveaux derives 17beta-oh 19-nor steroides substitues en 17alpha, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
|
|
DE3820948A1
(de)
|
1988-06-16 |
1989-12-21 |
Schering Ag |
10ss, 11ss-ueberbrueckte steroide
|
|
US4954490A
(en)
|
1988-06-23 |
1990-09-04 |
Research Triangle Institute |
11 β-substituted progesterone analogs
|
|
US5348729A
(en)
|
1988-11-30 |
1994-09-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Evaluative means for detecting inflammatory reactivity
|
|
DD289541A5
(de)
|
1989-08-04 |
1991-05-02 |
��@�K@�������������@�K@��������������@��������k�� |
Verfahren zur herstellung von 11beta-aryl-16 alpha, 17 alph-cyclohexanoestra-4,9-dienen
|
|
US5276023A
(en)
|
1989-08-08 |
1994-01-04 |
Roussel Uclaf |
19-nor-steroid esters
|
|
FR2651233B1
(fr)
|
1989-08-23 |
1991-12-13 |
Roussel Uclaf |
Nouveaux acides omega-phenylamino alcanouiques substitues sur le noyau aromatique par un radical derive de 19-norsterouides, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant.
|
|
US5173405A
(en)
|
1990-01-23 |
1992-12-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of arsenite to reversibly block steroid binding to glucocorticoid receptors in the presence of other steroid receptors
|
|
US5616458A
(en)
|
1990-03-14 |
1997-04-01 |
Board Of Regents, University Of Tx System |
Tripterygium wilfordii hook F extracts and components, and uses thereof
|
|
DE4042004A1
(de)
|
1990-12-22 |
1992-06-25 |
Schering Ag |
14(beta)-h-, 14- u. 15-en-11(beta)-aryl-4-estrene
|
|
US5439913A
(en)
|
1992-05-12 |
1995-08-08 |
Schering Aktiengesellschaft |
Contraception method using competitive progesterone antagonists and novel compounds useful therein
|
|
DE69500542T2
(de)
|
1994-05-19 |
1998-01-02 |
Akzo Nobel Nv |
11,21-Bisphenyl-19-nor-pregnan Derivate
|
|
US6051573A
(en)
|
1994-06-28 |
2000-04-18 |
Alcon Laboratories, Inc. |
Treatment of GLC1A glaucoma with non-steroidal glucocorticoid antagonists
|
|
US5696130A
(en)
|
1994-12-22 |
1997-12-09 |
Ligand Pharmaceuticals Incorporated |
Tricyclic steroid receptor modulator compounds and methods
|
|
EP1043325B1
(en)
|
1994-12-22 |
2004-06-16 |
Ligand Pharmaceuticals Incorporated |
Steroid receptor modulator compounds and methods
|
|
IL118974A
(en)
|
1995-08-17 |
2001-09-13 |
Akzo Nobel Nv |
History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
|
|
WO1998027986A1
(en)
|
1996-12-24 |
1998-07-02 |
Zymogenetics, Inc. |
Treatment agents and methods for treating type ii diabetes and symptoms of type ii diabetes
|
|
EP0903146A1
(en)
|
1997-09-23 |
1999-03-24 |
Applied Research Systems ARS Holdings N.V. |
21-Hydroy-6,19-oxidoprogesterone (210h-60p) as antiglucocorticoid
|
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
IL146057A
(en)
|
2000-10-27 |
2007-09-20 |
Pfizer Prod Inc |
A process for the preparation of modulators of a non-steroidal glucocorticoid receptor
|
|
WO2003043640A2
(en)
|
2001-11-23 |
2003-05-30 |
Akzo Nobel N.V. |
Treatment of major depressive disorder using glucocorticoid receptor antagonists
|
|
WO2004036377A2
(en)
|
2002-10-15 |
2004-04-29 |
Medtronic Inc. |
Configuring and testing treatment therapy parameters for a medical device system
|
|
JP2006508951A
(ja)
|
2002-11-05 |
2006-03-16 |
コーセプト セラピューティクス， インコーポレイテッド |
片頭痛を処置するための方法
|
|
PT1761497E
(pt)
|
2004-01-09 |
2008-09-25 |
Corcept Therapeutics Inc |
Azadecalinas moduladoras do receptor de glucocorticóides
|
|
AU2005222421B2
(en)
*
|
2004-03-09 |
2010-09-23 |
Corcept Therapeutics, Inc. |
Fused ring azadecalin glucocorticoid receptor modulators
|
|
PT1778236E
(pt)
|
2004-07-02 |
2010-10-19 |
Corcept Therapeutics Inc |
Moduladores do receptor de glucocorticóide de pirimidina modificada
|
|
JP2009535430A
(ja)
*
|
2006-05-02 |
2009-10-01 |
コーセプト セラピューティクス， インコーポレイテッド |
Ｉｌ−２を摂取している患者における抑うつを処置するためのグルココルチコイドレセプターｉｉアンタゴニストの使用
|
|
MX2009004385A
(es)
|
2006-10-23 |
2009-05-22 |
Merck & Co Inc |
Derivados de 2-[1-fenil-5-hidroxi-4alfa-metil-hexahidrociclopenta [f]indazol-5-il]etil fenilo como ligandos del receptor glucocorticoide.
|
|
US8598149B2
(en)
|
2007-08-30 |
2013-12-03 |
Corcept Therapeutics, Inc. |
Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists
|
|
EP2532350A1
(en)
|
2007-10-17 |
2012-12-12 |
Laboratoire HRA Pharma |
Pharmaceutical combination of a glucocorticoid receptor antagonist and a cortisol synthesis inhibitor for treating cushing's syndrome
|
|
ES2531040T3
(es)
|
2009-05-12 |
2015-03-10 |
Corcept Therapeutics Inc |
Formas sólidas y procedimiento de preparación
|
|
DK2685827T3
(en)
*
|
2011-03-18 |
2016-05-17 |
Corcept Therapeutics Inc |
PYRIMIDIN -cyclohexyl- glucocorticoid receptor MODULATORS
|
|
US8859774B2
(en)
|
2012-05-25 |
2014-10-14 |
Corcept Therapeutics, Inc. |
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
|
|
PT4119561T
(pt)
*
|
2012-05-25 |
2024-09-30 |
Corcept Therapeutics Inc |
Moduladores de recetores de glucocorticoides de azadecalina fundida com heteroaril-cetona
|
|
ITFI20120127A1
(it)
*
|
2012-06-21 |
2013-12-22 |
Valpharma Internat Spa |
Formulazioni per la preparazione di compresse per uso orale a rilascio immediato contenenti mifepristone a basso dosaggio, compresse così ottenute e loro processo di preparazione.
|
|
US20140170768A1
(en)
*
|
2012-12-14 |
2014-06-19 |
Joel R. L. Ehrenkranz |
Method for monitoring and assessing pituitary function
|
|
US9943526B2
(en)
|
2015-04-21 |
2018-04-17 |
Corcept Therapeutics, Inc. |
Optimizing mifepristone levels for cushing's patients
|
|
ES2865334T3
(es)
|
2015-08-13 |
2021-10-15 |
Corcept Therapeutics Inc |
Método de diagnóstico diferencial de síndrome de Cushing dependiente de ACTH
|